Tuesday, February 14, 2017

For medical schools, mission statements matter

Over the years, applicants whom I've interviewed for positions in the first-year medical student class at Georgetown have often asked how our school's mission statement influences the educational experiences and clinical services we provide:

Guided by the Jesuit tradition of Cura Personalis, care of the whole person, Georgetown University School of Medicine will educate a diverse student body, in an integrated way, to become knowledgeable, ethical, skillful, and compassionate physicians and biomedical scientists who are dedicated to the care of others and health needs of our society.

I never quite know how to answer this question. Like the aspirational mission statement of my previous employer, the Agency for Healthcare Research and Quality, which was "to improve the health of all Americans," Georgetown's statement doesn't offer an obvious path for how to produce physicians dedicated to the "health needs of our society." Although our Population Health Scholars Track gives select students perspectives and tools to address societal health needs on the population level, Georgetown consistently graduates a majority of medical subspecialists and produces few who will relieve growing national shortages of family physicians and psychiatrists. As for meeting the needs of rural and urban underserved populations, a 2010 study ranked us 102nd out of 141 U.S. medical schools in the percentage of physicians who were practicing in federally designated Health Professional Shortage Areas.

So are medical school mission statements just academic boilerplate, or do they really guide graduate specialty choice and practice location? This was the question that Dr. Christopher Morley and colleagues investigated in a fascinating study published in Family Medicine. A diverse panel of 37 medical students, educators, and administrators reviewed the mission statements of U.S. medical schools and rated them on a 5-point scale for social mission content, defined as "any language that reflects a goal of medical education to train practitioners capable of matching the needs of society and vulnerable populations or for the institution itself to serve vulnerable populations or regions." The mean of panelist ratings for each school's mission statement turned out to be a statistically significant predictor of the percentage of graduates who entered family medicine and the percentage who worked in Medically Underserved Areas/Populations.

As the study authors noted, these interesting associations could be interpreted a number of different ways:

It is not clear from these results if graduate career choice is influenced by the orientation of the institution, or if students who go on to work in these areas of medicine self-select into institutions because of a personal predilection to work in primary care or in underserved communities; however, it appears that medical schools with a proclaimed orientation toward producing physicians in primary care and/or physicians who provide care to underserved populations are achieving these missions.

Incidentally, I don't know how Georgetown's mission statement rated on the scale of social mission content, although I imagine that it would have fallen somewhere in the middle. Also unanswered is the philosophical question of what percentage of schools should be orienting their graduates toward Morley and colleagues' definition of social mission, rather than producing excellent physician-scientists, health executives, or some other standard of accomplishment.

For medical schools, mission statements matter. Perhaps we need a national mission statement for medical education in the United States, one that embraces and expands on the American Association of Medical Colleges' "improve the health of all." This national mission statement would recognize the shortcomings of our current physician workforce and explicitly aim to produce a mix of future medical school graduates who are dedicated and prepared to build the Culture of Health that America so desperately needs.


This post first appeared on Common Sense Family Doctor on June 11, 2015.

Tuesday, February 7, 2017

Obstructive sleep apnea: screening and home testing news

According to a recent article in American Family Physician, obstructive sleep apnea (OSA) is present in 2 to 14 percent of the general adult population, with a higher prevalence in older and obese persons. Most people are unaware of their diagnoses, either because they do not recognize symptoms or do not report them to physicians. Since it is hard to make an asymptomatic person feel better, is there any good reason to screen for OSA in asymptomatic adults? Screening advocates suggest that treating patients with moderate to severe OSA with continuous positive airway pressure (CPAP) reduces hypoxic episodes that could trigger cardiovascular events in patients with known vascular disease. However, a randomized trial seemed to refute this hypothesis. After almost 4 years of follow-up, the group that received CPAP reported slightly less daytime sleepiness, but had the same frequency of cardiovascular events as the control group.

The U.S. Preventive Services Task Force (USPSTF) considered this study and others in issuing a new recommendation statement on January 24th that concluded "the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults." The USPSTF found inadequate evidence that validated questionnaires accurately identify who will benefit from polysomnography (PSG) in asymptomatic populations (as opposed to those with suspected OSA). The Task Force also could not determine if CPAP or mandibular advancement devices improve health outcomes (mortality, cognitive impairment, motor vehicle crashes, and cardiovascular or cerebrovascular events) other than sleep-related quality of life.

Although an insufficient evidence statement is not necessarily a recommendation to not screen, Drs. Sachin Pendharkar and Fiona Clement argued in an editorial in JAMA Internal Medicine that the costs of screening for OSA (not considered by the Task Force) warrant clinicians doing just that. Based on the sensitivity and specificity of one widely used screening tool, and an OSA prevalence of 26% in the Medicare population, the authors estimate that $21 billion would be wasted on negative PSG tests, or $4.4 billion if less expensive home-based sleep studies were used instead.

On a related note, the comparative accuracy of home-based tests versus laboratory PSG in diagnosing OSA has been an actively studied topic. A 2014 practice guideline from the American College of Physicians recommended that portable sleep monitors (limited-channel sleep studies) only be used to diagnose OSA when PSG was not available. However, a randomized non-inferiority trial published in Annals of Internal Medicine found that patient outcomes after limited-channel studies were similar to those after PSG. This finding may be a blow to the for-profit sleep testing industry, but it is undoubtedly good news for my patients.


This post originally appeared in the AFP Community Blog.

Friday, February 3, 2017

Tom Price is a physician who doesn't understand cancer screening

If confirmed by the Senate, Dr. Tom Price will become the first medical doctor to lead the U.S. Department of Health and Human Services in 24 years. One might think that having completed medical school and practiced orthopedic surgery before entering politics might give him some extra insight into what works and what doesn't in medicine. But judging by a letter to then-HHS Secretary Kathleen Sebelius that he signed in 2011 objecting to the U.S. Preventive Services Task Force's draft recommendations on prostate cancer screening, Dr. Price either failed to learn anything in evidence-based medicine class or forgot everything he learned.

Price and colleagues wrote: "Since the [prostate-specific antigen] PSA test came into widespread use for cancer detection in the mid-1990s, the rate of deaths due to cancer has fallen by 40 percent." This statement reflects an association, not causation, and there is a serious problem with positing the latter based on the natural history of PSA-detected prostate cancers. In the European Randomized Study of Screening for Prostate Cancer (ERSPC), the only trial to conclude that PSA screening reduced deaths from prostate cancer, it took 9 years to observe any difference in prostate cancer deaths between the screening and control groups. But not only was the prostate cancer death rate falling in the U.S. long before any possible screening effect could have occurred, it was also falling in other countries (such as the United Kingdom) that were not employing PSA as a screening test.

The letter goes on to state that the percentage of potentially "curable" prostate cancers rose from 35 to nearly 90 percent after doctors started routinely screening with PSA, so it's obvious that the test works. Dr. Price, have you heard of lead-time and overdiagnosis bias? Even implementing a completely ineffective screening test, such as chest x-rays for lung cancer, will artificially increase survival rates and inflate the number of cancers amenable to surgery because a large percentage of these would never have been detected at all, if not for the test. (On this erroneous conclusion, Dr. Price is unfortunately in good company: a 2012 survey of primary care physicians found that two-thirds would recommend a cancer screening test supported by irrelevant changes in 5-year survival rates.)

Finally, the letter accused the USPSTF of having "cherry-picked" information rather than reviewing the totality of the evidence on PSA-based, which is laughable since it came in the same paragraph that Price and the other legislators highlighted the Goteburg, Sweden randomized trial (a subset of ERSPC) as "the best designed and controlled study." Talk about cherry-picking! Goteburg also happens to be the country with the most impressive-appearing benefit of screening; most of the other countries involved in ERSPC found no statistically significant mortality benefit, as did the U.S. in our own randomized trial.

These cancer epidemiology concepts I've mentioned aren't difficult to master; I teach them all the time to undergraduates and first-year medical students. Since Dr. Price clearly needs a refresher, I refer him to a previous instructional post I originally wrote for urologists. Patients can understand these concepts too, thanks to this excellent video decision aid that persuaded men to make more evidence-based decisions about PSA screening in a recent study published in Annals of Family Medicine.

Sunday, January 29, 2017

Diagnosis: self-inflicted wounds

Every so often, a team (or individual athlete) comes along that's so good that the only way they can be stopped is to beat themselves. When they lose, it's from a self-inflicted wound.

It's the Seattle Seahawks in the closing seconds of Super Bowl XLIX, throwing an underneath pass from the New England Patriots' 1-yard line that was intercepted instead of handing the football to one of the best running backs in the game for the winning score.

It's the number one-ranked tennis player in the final of a Grand Slam tightening up and double-faulting on match point.

It's one of the top pro golfers of an era on the fairway of the 17th hole of the final round of a major with a 4-shot lead, deciding to go for the green in one (and finding a bunker) rather than taking the safe layup.

It's the U.S. health care system, which should be the envy of the world, lavishing nearly $10,000 per American on health services each year, but wasting billions on excessive administrative costs, unnecessary and harmful interventions, a fragmented delivery system, rationing care by ability to pay, and colossally failing to invest in primary care and community services that are the foundation for good health outcomes.

It's President Trump's discriminatory (and possibly illegal) executive order to halt immigration from seven majority-Muslim countries under the guise of "national security." Did Osama bin Laden really believe that the result of the 9/11 attacks would be armies of jihadists lining up for more suicide strikes on the U.S.? Or instead, did the Al Qaeda leader perhaps envision an injured America turning in on itself and dying slowly from a torrent of self-inflicted wounds: racism, xenophobia, Islamophobia, among other epidemics of dark suspicion of those who aren't like us? Like many of you, my family has an immigration story, and I stand in solidarity with those unfortunate souls who are being turned away or detained tonight at the airports all over the country solely because of where they came from.

The patient - America - is in critical condition, but may yet be saved by heroic measures. Don't wait. Protest peacefully. Sign a petition. Call your Congressional representative. And remember the words of pastor Martin Niemöller, who spent seven years in a Nazi concentration camp:

First they came for the Socialists
And I did not speak out
Because I was not a Socialist

Then they came for the Trade Unionists
And I did not speak out
Because I was not a Trade Unionist

Then they came for the Jews
And I did not speak out
Because I was not a Jew

Then they came for me
And there was no one left to speak for me

Tuesday, January 24, 2017

Guest Post: Voting is a vital sign

- Matthew Brown, MD

As a family doctor who works with the underserved in Rochester, New York, I have seen what happens when people do not have access to primary and preventive care. I have seen people admitted for diabetic complications because they couldn't afford their insulin. I have seen people diagnosed with end-stage cancer because they couldn't afford screenings to catch it when it could have been treated successfully. I have seen strokes, and heart attacks, and kidney failure, and a hundred other things that happened because people had to choose between medicine and food. Between doctor's visits and having a roof over their heads. Between what they needed in the long-term and what they needed right at that moment.

Medical care shouldn't be a political issue. I didn't get into this gig hoping I would get to lobby my congressman, or attend rallies, or research Supreme Court decisions. The reason I worked so hard in college, in medical school, in residency and as an attending was to help people who needed help. And I hope most of the people whom I've had the honor and privilege of serving would see that, even if I failed, I was trying with all of my heart to do that.

But the truth is, if I limit myself to studying diseases and medicines and tests and screenings, I'm not really doing all I can. Because it's not just about that any longer. Because, for all of the talk some years ago about "death panels," we are now seeing what the real death panel is: poverty, lack of power, lack of access to care. Because if you're rich, you can afford health care. And if you're poor, you cannot. Full stop.

I ask my patients about non-medical things all the time. I ask them about work, and about seat-belts and bike helmets. I ask them about guns (and I would do so even if I worked in Florida, law be damned). I ask them about their families, and about their favorite sports teams. I ask them how their weekends went. But now I'm asking them one more question:

Are you registered to vote?

If the answer is yes, then I am thanking them, and urging them to make sure they do vote. In every election. If the answer is no, then I am handing them a voter registration form complete with postage, and asking them to fill it out, providing help if necessary. If they have a felony on their record, I am reviewing the New York state rules (able to vote once off parole). If they have immigration issues, I'm getting a social worker involved.

And this is where The Ask comes in, what I am asking of you:

If you are a primary care clinician who works with the underserved, start asking people if they are registered to vote, then help them to do it. It doesn't take long, and it is so important. If you are a nurse or staff member in a primary care office, get your physicians to do this (they'll listen to you; they need you more than you need them, believe me). If you don't have any of those roles but you know someone who does, then for goodness sake share this message with them. If you know someone who knows someone, share this with them. Heck, just share it on the off chance.

And because everything needs a stupid hashtag these days, here's this one: #VotingIsAVitalSign

It shouldn't be political, but it is.

Wednesday, January 18, 2017

What's in a name? Obesity, ABCD, and prediabetes

A recent position statement from the American Association of Clinical Endocrinologists and the American College of Endocrinology proposed replacing obesity with the term "adiposity-based chronic disease," or ABCD for short. The authors argued that this new term emphasizes that most persons with obesity will struggle with weight gain for their entire lives; encourages a complications-centric as opposed to body mass index-based management approach; and "avoids the stigmata [sic] and confusion" associated with obesity in popular culture. They also asserted that ABCD is more amenable to interventions based on the Chronic Care Model, which explicitly recognizes that screening and office-based management need to be adapted to the patient's unique environment.

None of these concepts should surprise family physicians, though, and after reading through the AACE/ACE statement, I was not sold on the benefits of the new term. Some patients with body mass indexes above 30 don't like the obesity label, but would they respond any more positively to the disease acronym ABCD? There are potential harms to consider, too. One of my American Family Physician colleagues felt that the new term was "intimidating" and "not at all patient centered," while another thought that it "only hides the issue [of obesity] instead of confronting it."

This discussion brought to mind another medical term often associated with overweight and obese patients: prediabetes. On one hand, being classified as "prediabetic" or at risk for this exceptionally common diagnosis may motivate obese patients to lose weight through improved diet and physical activity. On the other, the term prediabetes is misleading: many of these patients will not develop diabetes, and the diagnostic accuracy of the most common screening tests (hemoglobin A1c and fasting glucose levels) is poor, according to a systematic review published in the BMJ. Due to the tests' low sensitivity and specificity, some persons are incorrectly diagnosed with prediabetes, and others who might actually benefit from interventions to prevent diabetes are falsely reassured. Therefore, the review authors concluded, "'screen and treat' policies alone are unlikely to have substantial impact on the worsening epidemic of type 2 diabetes."

For all its limitations, obesity is a diagnosis with well-established clinical utility. It is less clear how many patients have been helped (or harmed) by being diagnosed with prediabetes. With more study, adiposity-based chronic disease might someday become a useful term, but the current case for more widespread use is unconvincing.


This post first appeared on the AFP Community Blog.